French drugmaker Sanofi sacks CEO, shares drop
By Natalie Huet and Noëlle Mennella PARIS (Reuters) – Sanofi's board ousted its chief executive of six years on Wednesday, criticizing him for an authoritarian management style that was often popular with investors as he lifted the French drugmaker onto the global stage. Shares in France's second-biggest listed company, battered by days of uncertainty over the future of CEO Chris Viehbacher and a warning over slowing growth at its key diabetes business, fell a further 4 percent in afternoon trade. …
